Age-related macular degeneration (AMD), a set of age-related macular disease, is induced by a variety of factors. New intervention Methods help us to understand the AMD pathogenesis further; however, we only have limited knowledge of these novel Methods . To improve diagnosis and treatment practices of AMD, it is a priority to propose a standardized clinical procedure of AMD management in China. The Chinese Ocular Fundus Association has just proposed a Chinese AMD clinical pathway based on experts prime;opinions and evidence based medicine. This clinical guideline is implementable for different stages and subtypes of AMD patients, and hopefully will be updated frequently with more clinical practice. Implementing this AMD pathway in China will improve the quality of clinical practice and research of AMD in China.
Citation： 黎晓新. Promotion and implementing Chinese Clinical Pathway of Age-related Macular Degeneration to standardize the diagnosis and treatment practices of age-related macular degeneration in China. Chinese Journal of Ocular Fundus Diseases, 2013, 29(4): 341-342. doi: Copy